Alpaslan ALP, Cem ŞİMŞEK, Osman DAĞ, Tolga YILDIRIM, Abdullah Tarık ASLAN, Şefika AYAR, Cavanşir VAHABOV, Hakan GÖKER, Yahya BÜYÜKAŞIK, Halis ŞİMŞEK, H. Yasemin BALABAN

Lack of awareness of Hepatitis B screening and vaccination in high-risk group

Background/aim: Hepatitis B virus (HBV) vaccination rates are insufficient in high-risk patients worldwide. This study aimed to investigate the screening, immunization, and vaccination rates in three high-risk groups for HBV infection: allogeneic hematopoietic stem cell transplantation (AHSCT), renal transplantation (RT), and chronic hepatitis C (CHC) groups. Materials and methods: The serological data of consecutive patients between 2014 and 2019 were reviewed using the hospital database. Results: The HBV screening rates were 100.0%, 90.4%, and 82.4% in the AHSCT, CHC, and RT groups, respectively (p = 0.003). The immunization rates against HBV through either previous exposure or vaccination were 79.5%, 71.7%, and 46.5% in the AHSCT, RT, and CHC groups, respectively (p < 0.001). The HBV vaccination rate was significantly low in the CHC group (71.5%, 69.0%, 34.6% in the AHSCT, RT, and CHC groups, respectively, p < 0.001). If patients lost their immunity due to immunosuppressive therapy were accounted, the vaccination rates increased to 95.2% in the AHSCT group and 72.9% in the RT group. The rate of annual screening for HBV status was 97.9% in the AHSCT group, but it was only 23.9% in the RT group. Conclusion: HBV screening and vaccination rates were significantly lower in the RT and CHC groups than in the AHSCT group.Key words: Vaccination, Hepatitis B virus, immunity

PDF

___

1. Salama, II, Sami SM, Said ZN, Salama SI, Rabah TM et al. Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy. Vaccine 2018; 36: 2005-2011. doi: 10.1016/j.vaccine.2018.02.103
2. Akyıldız M, Ahıskalı E, Zeybel M, Yurdaydın C. Regional epidemiology, burden and management of hepatits B virus in the Middle East. Clinical Liver Disease 2019; 14: 212-214. doi: 10.1002/cld.887
3. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. European Journal of Epidemiology 2006; 21: 299-305. doi: 10.1007/s10654-006-0001-2
4. Üner A, Kırımi E, Tuncer İ, Ceylan A, Türkdoğan MK et al. Seroepidemiology of hepatitis B virus infection in children in the Eastern Anatolia. Eastern Journal of Medicine 2001; 6: 40- 42.
5. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clinical Microbiology and Infection 2015; 21: 1020-1026. doi: 10.1016/j. cmi.2015.06.028
6. Schillie S, Vellozzi C, Reingold A, Harris A, Haber P et al. Prevention of hepatitis B virus infection in the United States: recommendation of the Advisory Committee on Immunization Practices. MMWR. Recommendations and Reports 2018; 67: 1-31. doi: 10.15585/mmwr.rr6701a1
7. Burton CE, Doucette KE, Mabilangan CA, Plitt SS, Lee BE et al. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center. Transplant Infectious Disease 2016; 18: 520-528. doi: 10.1111/ tid.12558
8. Williams WW, Lu PJ, O’Halloran A, Kim DK, Ghroskopf LA et al. Surveillance of vaccination coverage among adult populations—United States, 2015. MMWR CDC Surveillance Summaries 2017; 66: 1–28. doi: 10.15585/mmwr.ss6611a1
9. Stroffolini T, Sagnelli E, Sagnelli C, Smedile A, Furlan C et al. The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy. Digestive and Liver Disease 2019; 51: 434-437. doi: 10.1016/j.dld.2018.09.010
10. Launay O, Le Strat Y, Tosini W, Kara L, Quelet S et al. Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: a pre-post cluster randomized study. Clinical Microbiology and Infection 2014; 20: 1033-1039. doi: 10.1111/1469-0691.12689
11. Bini EJ, Perumalswami PV. Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: prevalence, racial/ethnic differences, and viral interactions. Hepatology 2010; 51: 759-766. doi: 10.1002/hep.23461
12. Urbini Dos Santos C, Sevá-Pereira T, Alves-Filho G, Lorena SL, Soares EC et al. Changes in serological markers of hepatitis B virus after renal transplantation. Transplantation Proceedings 2008; 40: 749-751. doi: 10.1016/j.transproceed.2008.02.066
13. Çakar MK, Suyani E, Sucak GT, Altindal Ş, Aki SZ et al. HBV-related events after allogeneic hematopoetic stem cell transplantation in a center from Turkey. Annals of Hematology 2013; 92: 395-402. doi: 10.1007/s00277-012-1620-1